loadpatents
name:-0.0071620941162109
name:-0.0059719085693359
name:-0.00061893463134766
Peltz; Stuart Patent Filings

Peltz; Stuart

Patent Applications and Registrations

Patent applications and USPTO patent grants for Peltz; Stuart.The latest application filed is for "methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated rna decay".

Company Profile
0.4.4
  • Peltz; Stuart - Piscataway NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay
App 20060134681 - Beckmann; Holger ;   et al.
2006-06-22
Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay
Grant 7,026,122 - Beckmann , et al. April 11, 2
2006-04-11
Subfamily of RNA helicases which are modulators of the fidelity of translation termination and uses thereof
Grant 6,989,256 - Peltz , et al. January 24, 2
2006-01-24
Subfamily of RNA helicases which are modulators of the fidelity of translation termination and uses thereof
App 20040115787 - Peltz, Stuart ;   et al.
2004-06-17
Subfamily of RNA helicases which are modulators of the fidelity of translation termination and uses thereof
Grant 6,630,294 - Peltz , et al. October 7, 2
2003-10-07
Method of modulating the efficiency of translation termination and degradation of aberrant mRNA involving a surveillance complex comprising human Upf1p,eucaryotic release factor 1 and eucaryotic release factor 3
App 20030032158 - Peltz, Stuart ;   et al.
2003-02-13
Methods of assaying for compounds that inhibit premature translation termination and nonsense-mediated RNA decay
App 20030008317 - Beckmann, Holger ;   et al.
2003-01-09
Method Of Modulating The Efficiency Of Translation Termination And Degradation Of Aberrant Mrna Involving A Surveillance Complex Comprising Human Upf1p, Eucaryotic Release Factor 1 And Eucaryotic Release Factor 3
Grant 6,486,305 - Peltz , et al. November 26, 2
2002-11-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed